Difluoromethylbenzoxazole Pyrimidine Thioether Derivatives: A Novel Class of Potent Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors

Citations Over TimeTop 14% of 2011 papers

Abstract

This paper reports the synthesis and antiviral properties of new difluoromethylbenzoxazole (DFMB) pyrimidine thioether derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors. By use of a combination of structural biology study and traditional medicinal chemistry, several members of this novel class were synthesized using a single electron transfer chain process (radical nucleophilic substitution, S(RN)1) and were found to be potent against wild-type HIV-1 reverse transcriptase, with low cytotoxicity but with moderate activity against drug-resistant strains. The most promising compound 24 showed a significant EC(50) value close to 6.4 nM against HIV-1 IIIB, a moderate EC(50) value close to 54 μM against an NNRTI resistant double mutant (K103N + Y181C), but an excellent selectivity index >15477 (CC(50) > 100 μM).

Related Papers

• → Recent Progress in Developing Thioether-Containing Ligands for Catalysis Applications(2023)12 cited
• → A novel thioether linker: Chemical synthesis of a HIV-1 protease analogue by thioether ligation(1995)54 cited
• → Thioether ligation in Co(III) complexes with carboxamido nitrogens as donors: implications on the coordination structure of the cobalt site in nitrile hydratase(2001)26 cited
• → Phenylation of Platinum(II) Thioether Complexes by Tetraphenylborate(III) in Solid State and Nitromethane Solution(1993)24 cited
• → Efficient Pyrimidine N‐1‐Alkylation via Activation of Electron Rich Olefins with Oxoammonium Salts: Synthesis of Methoxy TEMPO Substituted Pyrimidine Nucleoside Analogs(2004)15 cited